What is OnKure Therapeutics, Inc.'s share price today?
OnKure Therapeutics, Inc. (OKUR) share price today is $2.47 as of October 27, 2026 at 1:29 AM IST. The stock touched a day high of $2.62 and a day low of $2.38.What exchange does OnKure Therapeutics, Inc. stock trade on, and under what ticker symbol?
OnKure Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol OKUR.What is OnKure Therapeutics, Inc.'s market capitalization?
OnKure Therapeutics, Inc.'s market capitalization is $102.05M as of October 27, 2026 at 1:29 AM IST.What is OnKure Therapeutics, Inc.'s price-to-earnings (P/E) ratio?
OnKure Therapeutics, Inc.'s price-to-earnings (P/E) ratio is N/A as of October 26, 2026.What is OnKure Therapeutics, Inc.'s price-to-book (P/B) ratio?
OnKure Therapeutics, Inc.'s price-to-book (P/B) ratio is 0.70 as of October 26, 2026.Can Indian investors buy OnKure Therapeutics, Inc. shares?
Yes, You can buy OnKure Therapeutics, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in OnKure Therapeutics, Inc. shares from India?
Indian investors can buy OnKure Therapeutics, Inc. shares in three steps: 1. Search OnKure Therapeutics, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from OnKure Therapeutics, Inc. shares for Indian investors?
Since OnKure Therapeutics, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in OnKure Therapeutics, Inc. shares via Tickertape?
Indian investors can start investing in OnKure Therapeutics, Inc. (OKUR) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 4.0404 shares at the current price of $2.47.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 6 analysts reports
Price Upside
+515.08%
Earnings Growth
+58.47%
Rev. Growth
—
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
All values in $ Thousand
All values in $ Thousand
Earnings Per Share Forecast
Earnings Per Share Forecast
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0.15 | -0.01 | -0.01 | -0.41 | -0.21 | -0.21 | - | -0.20 | -0.20 | - |
| Net Income | -9.53 | -14.13 | -3.69 | -35.19 | -15.92 | -15.39 | -14.69 | -13.50 | -15.15 | -15.34 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| OnKure Therapeutics, Inc. | - | 0.70 | - |
| AbbVie Inc | 80.68 | 50.45 | 0.53 |
| Amgen Inc | 27.28 | 17.56 | 2.28 |
The 12-month consensus target implies 515.08% growth, versus a trailing 3-year CAGR of -68.12%.